ID CORE XT
Category
Diagnostics and Personalised Medicine
Register type
Biotech Sanitaria
Company name
Product / Service
ID CORE XT
Type
Diagnostic
Therapeutic area
Sangre y sistema linfático
Properties/Indication
Blood Group Genotyping
The ID CORE XT™ test uses Polymerase Chain Reaction (PCR) amplification to obtain large amounts of the target sequence encoding human erythrocyte antigens (HEAs).
The ID CORE XT™ test uses Polymerase Chain Reaction (PCR) amplification to obtain large amounts of the target sequence encoding human erythrocyte antigens (HEAs).
Application
ID CORE XT is a qualitative, PCR-based and hybridization-based genotyping test for the simultaneous identification of multiple alleles encoding human erythrocyte antigens (HEAs) in genomic DNA extracted from whole blood specimens collected in EDTA. The test interrogates 29 polymorphisms for 53 HEA Alleles and 37 Antigens prediction of the blood group systems Rh, Kell, Kidd, Duffy, MNS, Diego, Dombrock, Colton, Cartwright, and Lutheran, as an alternative to serology. ID CORE XT can be used to genotype and predict the Red Blood Cells (RBC) phenotype in patients and/or blood donors. The product is intended for professional use in a laboratory environment.
ID CORE XT ANALYSIS SOFTWARE is a qualitative software application designed to transform Luminex system (Luminex 200 or FLEXMAP 3D) readings (CSV output) from Progenika Biopharma´s ID CORE XT assay into a genotype and predicted phenotype for each of the blood group systems analyzed in the assay. The product is intended for professional use in a laboratory environment
ID CORE XT ANALYSIS SOFTWARE is a qualitative software application designed to transform Luminex system (Luminex 200 or FLEXMAP 3D) readings (CSV output) from Progenika Biopharma´s ID CORE XT assay into a genotype and predicted phenotype for each of the blood group systems analyzed in the assay. The product is intended for professional use in a laboratory environment
Development phase
Registration
Phases developed in Spain
R&D
Registration
Research location
España
Commercialized
✔
Market release year
2014